相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。THROMBOMODULIN ALFA IN THE TREATMENT OF INFECTIOUS PATIENTS COMPLICATED BY DISSEMINATED INTRAVASCULAR COAGULATION: SUBANALYSIS FROM THE PHASE 3 TRIAL
Naoki Aikawa et al.
SHOCK (2011)
Expert consensus for the treatment of disseminated intravascular coagulation in Japan
Hideo Wada et al.
THROMBOSIS RESEARCH (2010)
Proteolytic cleavage of high mobility group box 1 protein by thrombin - Thrombomodulin complexes
Takashi Ito et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2008)
Efficacy and safety of recombinant human soluble thrombomodulin (ART-123) in disseminated intravascular coagulation: results of a phase III, randomized, double-blind clinical trial
H. Saito et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2007)
A multicenter, prospective validation of disseminated intravascular coagulation diagnostic criteria for critically ill patients: Comparing current criteria
S Gando et al.
CRITICAL CARE MEDICINE (2006)
Clinical review: Molecular mechanisms underlying the role of antithrombin in sepsis
Christian J. Wiedermann
CRITICAL CARE (2006)
Treatment effects of high-dose antithrombin without concomitant heparin in patients with severe sepsis with or without disseminated intravascular coagulation
J Kienast et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2006)
Antithrombin, heparin, and heparan sulfate
SM Opal et al.
CRITICAL CARE MEDICINE (2002)
Activation of the fibrinolytic system and utilization of the coagulation inhibitors in sepsis: comparison with severe sepsis and septic shock
AC Mavrommatis et al.
INTENSIVE CARE MEDICINE (2001)
High-dose a randomized antithrombin III in severe sepsis -: A randomized controlled trial
BL Warren et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2001)
Efficacy and safety of recombinant human activated protein C for severe sepsis.
GR Bernard et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
分享论文
